Vaginal drug delivery insert
Latest The Upjohn Company Patents:
- 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1-pyrazolo[4,3-]pyrimidin-5-yl) piperidine-4-carboxylic acid and salts thereof
- CRYSTALLINE FORMS OF 3-[5-CHLORO-4-[(2,4-DIFLUOROBENZYL) OXY]-6-OXOPYRIMIDIN-1(6H)-YL]-N-(2-HYDROXYETHYL)-4-METHYLBENZAMIDE
- Anti-bacterial Vaccine Compositions
- Cellular permissivity factor for viruses and uses thereof
- METHOD OF ADMINISTERING AN INJECTABLE ANTIBIOTIC TO AN ANIMAL
Description
FIG. 1 is a right front perspective view of a vaginal drug delivery insert embodying our new design;
FIG. 2 is a front view thereof;
FIG. 3 is a rear view thereof;
FIG. 4 is a left side view thereof, the right side view being a mirror image of the left side view;
FIG. 5 is a top view thereof; and,
FIG. 6 is a bottom view thereof.
Referenced Cited
Patent History
Patent number: D350601
Type: Grant
Filed: Dec 19, 1991
Date of Patent: Sep 13, 1994
Assignee: The Upjohn Company (Kalamazoo, MI)
Inventors: David W. Osborne (St. Louis, MO), Charles R. Whitman (Augusta, MI)
Primary Examiner: A. Hugo Word
Assistant Examiner: I. Simmons
Law Firm: Flynn, Thiel, Boutell & Tanis
Application Number: 7/810,815
Type: Grant
Filed: Dec 19, 1991
Date of Patent: Sep 13, 1994
Assignee: The Upjohn Company (Kalamazoo, MI)
Inventors: David W. Osborne (St. Louis, MO), Charles R. Whitman (Augusta, MI)
Primary Examiner: A. Hugo Word
Assistant Examiner: I. Simmons
Law Firm: Flynn, Thiel, Boutell & Tanis
Application Number: 7/810,815
Classifications